Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 883 of 6351
-
Could a 20-Minute music session soothe sleep and fear in preterm birth threat?
Symptom relief CompletedThe scope of the study covers the effects of music therapy on risk perception levels and sleep quality in pregnant women hospitalized due to the diagnosis of premature birth threat.
Sponsor: Sakarya University • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Tailored timing of radioactive therapy may boost tumor control in NETs
Disease control Recruiting nowThere are several ways of personalizing PRRT (peptide receptor radionuclide treatment) in NEN (neuroendocrine neoplasia). Nevertheless, the current treatment regimen is not personalized. This trial aims to compare personalized PRRT to non-personalized PRRT in terms of safety, eff…
Phase 3 • Sponsor: Lund University Hospital • Aim: Disease control
Last updated Jun 26, 2026 16:10 UTC
-
New vaccine targets KRAS mutation in advanced lung cancer trial
Disease control Recruiting nowThis is a single institution, Phase 1 study for patients with Stage III/IV unresectable Kirsten rat sarcoma (KRAS) mutated NSCLC to evaluate safety of the pooled mutant-KRAS peptide vaccine (KRAS peptide vaccine) with polyinosinic-polycytidylic acid (poly-ICLC) adjuvant in combin…
Phase 1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New hope for advanced throat cancer: study tests smarter treatment for spread to neck nodes
Disease control Recruiting nowThis is a multi-center, multidisciplinary, open-label, randomized controlled prospective clinical study.
Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Hope for Alzheimer's agitation: new drug enters final testing
Symptom relief Recruiting nowThis study will be conducted to evaluate the efficacy, safety, tolerability, and pharmacokinetics of masupirdine compared to placebo for the treatment of agitation in participants with dementia of the Alzheimer's type.
Phase 3 • Sponsor: Suven Life Sciences Limited • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Supercharged donor cells aim to stop blood cancer relapse after transplant
Disease control Recruiting nowThis is a multi-center, non-randomized, concurrent controlled, multi-arm, Phase 1 interventional, open-label, biologic assignment-based umbrella study evaluating the feasibility, safety and preliminary efficacy of an escalating dose regimen of up to 2 doses of TSC-100 and TSC-101…
Phase 1 • Sponsor: TScan Therapeutics, Inc. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Can a common antibiotic shield the brain after a stroke?
Disease control CompletedMinocycline is the second generation of tetracycline. Because of its lipophilicity, it has high penetrance of blood-brain barrier. Animal model studies have shown that minocycline can reduce cerebral damage after ischemic stroke, and its mechanism involves multiple molecular path…
Phase 4 • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Could a breathing exercise and music tame cancer treatment fatigue?
Symptom relief CompletedAim: This study was conducted as a randomized controlled experimental study to determine the effect of integrative therapies on fatigue management and qualiy of life in cancer patients receiving immunotherapy. Materials and Methods: In the study 60 patients, 30 in the interventi…
Sponsor: Saglik Bilimleri Universitesi • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
New hope for Tough-to-Treat blood cancer: MK-1045 enters human trials
Disease control Recruiting nowResearchers are looking for new ways to treat people with a type of blood cancer called precursor B-cell Acute Lymphoblastic Leukemia (B-ALL) that is relapsed- the cancer has come back after treatment, or refractory - the current treatment has stopped working to slow or stop canc…
Phase 1/2 • Sponsor: MSD R&D (China) Co., Ltd. • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Supercharged immune cells take on Hard-to-Treat lymphoma
Disease control Recruiting nowThis study is for patients that have a type of lymph gland disease called Hodgkin or non-Hodgkin Lymphoma or T/NK-lymphoproliferative disease which has come back or has not gone away after treatment, including the best treatment the investigators know for these diseases. Some pa…
Phase 1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New pill could tame rare Muscle-Skin disease
Disease control OngoingThis is a phase 3, multicenter, randomized, placebo-controlled, double-blind study of treatment with brepocitinib (TYK2/JAK1 inhibitor) in adults with dermatomyositis (DM). The primary objective of this study is to assess the efficacy of two dose levels of brepocitinib in compari…
Phase 3 • Sponsor: Priovant Therapeutics, Inc. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Army tests IV antiviral against Kidney-Damaging hemorrhagic fever
Disease control PausedMultisite protocol to provide IV Ribavirin treatment to patients with probable or suspected case of Hemorrhagic Fever with Renal Syndrome (HFRS)
Phase 2 • Sponsor: U.S. Army Medical Research and Development Command • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New pill shows promise for tough lung cancer
Disease control Recruiting nowThis is an open label phase I/phase II clinical study designed to evaluate the safety, tolerability, pharmacokinetics, preliminary efficacy of Dositinib in participants of locally advanced or metastatic non-small cell lung cancer with positive EGFR mutation.
Phase 1/2 • Sponsor: Henan Genuine Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New drug offers hope for patients who Can't tolerate sunlight
Disease control CompletedThis is a Phase 2, multi-center, double-blind, placebo-controlled, parallel group study of bitopertin to evaluate the safety, tolerability, efficacy, and PPIX concentration change in participants with EPP. Participants may roll over to an open label extension portion after comple…
Phase 2 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New pill combo aims to tackle tough leukemia
Disease control Recruiting nowThis is a multi-center open clinical study aimed at evaluating the efficacy and safety of Clifutinib Besylate combined with chemotherapy in newly-treated adult subjects with AML
Phase 1/2 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Can a powerful drug cocktail halt multiple myeloma before it starts?
Disease control OngoingBackground: Multiple myeloma (MM) is a tumor in which malignant plasma cells accumulate in the bone marrow. It can cause organ damage and is not curable. Researchers want to see if a combination drug treatment can help. Objective: To try to prevent or slow down developing MM a…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Ayahuasca or esketamine: which eases depression better?
Symptom relief CompletedDouble-blind, randomized trial comparing 4 weekly doses of oral ayahuasca and esketamine in patients with major depression.
Phase 2 • Sponsor: University of Sao Paulo • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Can a phone app tame gestational diabetes?
Disease control Recruiting nowGestational diabetes mellitus (GDM) is an increasing public health challenge. Innovative, effective and scalable lifestyle interventions to support women with GDM to manage their disease and to prevent adverse obstetric and neonatal outcomes as well as later morbidity are request…
Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Brain zaps guided by scans: a new hope for untreatable depression?
Disease control Recruiting nowTreatment resistant depression remains a major problem for individuals and society. Surgical procedures may provide relief for some of these patients. The most frequently considered surgical approach is deep brain stimulation (DBS) of a part of the brain called the subcallosal ci…
Sponsor: Nader Pouratian • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Can a new bone graft match the gold standard for spinal fusion?
Disease control Recruiting nowThe aim of this study is to prospectively investigate the potential for bony fusion of ViviGen® bone graft substitute in comparison to rhBMP-2 in monosegmental ALIF procedure L5/S1 and in monosegmental XLIF procedure L4/5
Sponsor: Lindenhofgruppe AG • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC